An efficient, flexible, modern laboratory that’s brimming with state-of-the-art equipment and follows the latest trends in analyticalchemistry while respecting good old-fashioned chemical processes. Welcome to QUINTA-ANALYTICA’s R&D department.

The core task of this department comprises the development of new analytical methods where (U)HPLC equipment is used for a variety of known detectors like DAD-UV, fluorescence, or ELSD. And for the cases where HPLC is not enough, our LC/MS system with linear ion trap mass spectrometer can be fired up in order to improve selectivity or specificity, especially in trace analyses.

Sounds complex, and indeed it is; but Libor Hoplíček and his team of innovative experts work tirelessly to carry out research in many interesting areas, including the determination and isolation of impurities, accelerated stabilities and degradation studies, de-formulation (reverse engineering) studies, and extractable/leachable analyses to name just a few.

If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further. Contact Libor and his team for a no-obligation discussion.

Additional News

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.